Elevance Health Investing Cash Flow decreased by 34.2% to -$1.64B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1694.2%, from $103.00M to -$1.64B. Over 3 years (FY 2021 to FY 2024), Investing Cash Flow shows an upward trend with a -18.8% CAGR.
Typically negative for growing companies as they reinvest cash; a positive value suggests the company is liquidating assets faster than it is buying them.
The aggregate sum of all cash inflows and outflows related to a company's long-term investments and capital assets. It s...
Mature companies with high cash flow often show large negative values here as they recycle profits into new growth or financial instruments.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$4.93B | -$1.44B | -$966.00M | -$1.58B | -$2.02B | -$1.25B | $0.00 | -$3.18B | -$672.00M | -$687.00M | -$1.03B | -$2.31B | -$818.00M | -$401.00M | -$1.64B | $103.00M | -$687.00M | -$1.22B | -$1.64B |
| QoQ Change | — | +70.8% | +32.9% | -63.4% | -28.3% | +38.4% | +100.0% | — | +78.9% | -2.2% | -49.8% | -124.5% | +64.6% | +51.0% | -308.5% | +106.3% | -767.0% | -78.2% | -34.2% |
| YoY Change | — | — | — | — | +58.9% | +13.4% | +100.0% | -101.8% | +66.8% | +44.9% | — | +27.4% | -21.7% | +41.6% | -59.2% | +104.5% | +16.0% | -205.2% | <-999% |